Fibrobiologics Inc (FBLG)

Feb 24, 2025

Fibrobiologics stock plunges to 52-week low of $1.04 By Investing.com - Investing.com Australia

Feb 24, 2025

Feb 24, 2025

Fibrobiologics stock plunges to 52-week low of $1.04 - Investing.com India

Feb 24, 2025

Feb 24, 2025

FBLG: Analyst Day Provides In-Depth Overview of Pipeline… - MSN

Feb 24, 2025

Feb 18, 2025

FibroBiologics' (FBLG) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Feb 18, 2025

Feb 15, 2025

Exploring Growth Opportunities In FibroBiologics Inc (NASDAQ: FBLG) - Stocks Register

Feb 15, 2025

Feb 15, 2025

D. Boral Capital Reaffirms “Buy” Rating for FibroBiologics (NASDAQ:FBLG) - Defense World

Feb 15, 2025

Feb 11, 2025

Should This Give FibroBiologics Inc (NASDAQ: FBLG) Investors Sleepless Nights? - Stocks Register

Feb 11, 2025

Feb 11, 2025

FibroBiologics Inc (FBLG) stock analysis: A comprehensive overview - US Post News

Feb 11, 2025

Feb 10, 2025

FBLG (FibroBiologics Inc) may reap gains as insiders became active recently - Knox Daily

Feb 10, 2025

Feb 08, 2025

FBLG Stock Price and Chart — NASDAQ:FBLG - TradingView

Feb 08, 2025

Feb 08, 2025

FibroBiologics issues shares to fulfill commitment fee - MSN

Feb 08, 2025

Feb 07, 2025

FibroBiologics issues shares to fulfill commitment fee By Investing.com - Investing.com Australia

Feb 07, 2025

Feb 07, 2025

FibroBiologics Inc (FBLG) Stock: Navigating a Year of Volatility - The InvestChronicle

Feb 07, 2025

Feb 07, 2025

FibroBiologics Inc (NASDAQ: FBLG) Has Decreased By -81.41 Percent This Year. Is It A Better Buy Than Others? - Marketing Sentinel

Feb 07, 2025

Feb 07, 2025

Should You Invest in FibroBiologics Inc (FBLG) Now? - The News Heater

Feb 07, 2025

Feb 05, 2025

FibroBiologics, Inc. to Host Analyst Day on Fibroblast-Based Therapeutics in New York on February 12, 2025 - Nasdaq

Feb 05, 2025

Feb 05, 2025

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates - GlobeNewswire

Feb 05, 2025

Feb 05, 2025

Exclusive Analyst Day: FibroBiologics to Unveil Future of Fibroblast Therapeutics - StockTitan

Feb 05, 2025

Feb 04, 2025

FibroBiologics And 2 Other US Penny Stocks To Watch - Simply Wall St

Feb 04, 2025

Jan 29, 2025

BlackRock, Inc. Increases Stake in FibroBiologics Inc - GuruFocus.com

Jan 29, 2025

Jan 24, 2025

FibroBiologics approves executive bonuses for fiscal 2024 - MSN

Jan 24, 2025

Jan 24, 2025

FibroBiologics approves executive bonuses for fiscal 2024 By Investing.com - Investing.com Canada

Jan 24, 2025

Jan 24, 2025

FibroBiologics, Inc. (NASDAQ:FBLG) Shares Bought by Barclays PLC - Defense World

Jan 24, 2025

Jan 17, 2025

Jane Street Group LLC Acquires Shares of 11,852 FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World

Jan 17, 2025

Jan 09, 2025

Geode Capital Management LLC Acquires 284,047 Shares of FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World

Jan 09, 2025

Jan 09, 2025

Barclays PLC Buys 31,331 Shares of FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World

Jan 09, 2025

Jan 03, 2025

FibroBiologics, Inc. (NASDAQ:FBLG) Shares Bought by State Street Corp - Defense World

Jan 03, 2025

Jan 01, 2025

FibroBiologics Secures Second Tranche of $5 Million Financing - Defense World

Jan 01, 2025

Dec 31, 2024

FibroBiologics Announces $25 Million Financing - citybiz

Dec 31, 2024

Dec 30, 2024

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing - GlobeNewswire

Dec 30, 2024

Dec 30, 2024

FibroBiologics Secures Second $5M Tranche of $25M Equity Purchase Agreement with Yorkville Advisors - StockTitan

Dec 30, 2024

Dec 30, 2024

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing - The Manila Times

Dec 30, 2024

Dec 30, 2024

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing - GlobeNewswire Inc.

Dec 30, 2024

Dec 28, 2024

FibroBiologics (NASDAQ:FBLG) Receives Buy Rating from D. Boral Capital - Defense World

Dec 28, 2024

Dec 27, 2024

D. Boral Capital Reiterates Buy Rating for FibroBiologics (NASDAQ:FBLG) - MarketBeat

Dec 27, 2024

Dec 25, 2024

**FibroBiologics Enters Standby Equity Purchase Agreement for $25 Million Financing** ** - Defense World

Dec 25, 2024

Dec 24, 2024

FibroBiologics announces $25 million financing - MSN

Dec 24, 2024

Dec 23, 2024

FibroBiologics, Inc. announced that it expects to receive $15 million in funding from Yorkville Advisors Global LP - Marketscreener.com

Dec 23, 2024

Dec 23, 2024

FibroBiologics secures $25 million equity deal with Yorkville - Investing.com

Dec 23, 2024

Dec 23, 2024

FibroBiologics Secures $25M Equity Agreement for Trials - TipRanks

Dec 23, 2024

Dec 23, 2024

FibroBiologics Secures $25M Financing Deal to Advance Clinical Trials in Diabetic Foot Ulcers, Psoriasis - StockTitan

Dec 23, 2024

Dec 22, 2024

FibroBiologics finalizes agreement and terminates warrant By Investing.com - Investing.com Canada

Dec 22, 2024

Dec 22, 2024

FibroBiologics finalizes agreement and terminates warrant - Investing.com

Dec 22, 2024

Dec 22, 2024

Ionq Inc (IONQ-N) QuotePress Release - The Globe and Mail

Dec 22, 2024

Dec 17, 2024

FibroBiologics, Inc. (NASDAQ:FBLG) Short Interest Update - MarketBeat

Dec 17, 2024

Dec 13, 2024

Rodman & Renshaw Initiates Coverage of FibroBiologics (FBLG) with Buy Recommendation - MSN

Dec 13, 2024

Dec 12, 2024

FibroBiologics (NASDAQ:FBLG) Coverage Initiated at Rodman & Renshaw - MarketBeat

Dec 12, 2024

Dec 03, 2024

FibroBiologics, Inc. (NASDAQ:FBLG) Short Interest Up 7.2% in November - MarketBeat

Dec 03, 2024